Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
26.23
+1.77 (7.24%)
Jul 30, 2026, 2:11 PM EDT - Market open
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $795.55 million as of July 30, 2026. Its market cap has increased by 69.77% in one year.
Market Cap
795.55M
Enterprise Value
561.19M
1-Year Change
69.77%
Ranking
Category
Stock Price
$26.23
ChartMarket Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $795.55M, an increase of 546.53%. That is a compound annual growth rate of 30.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 795.55M | -29.93% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 3.71B |
| GRAIL | 3.03B |
| NeoGenomics | 2.08B |
| GeneDx Holdings | 2.04B |
| CareDx | 1.87B |
| Personalis | 1.27B |
| Freenome | 1.15B |
| OPKO Health | 1.00B |